Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SeraCare™ ACCURUN™ QC Serology Multi-Marker Negative Controls
Shop All SeraCare Life Sciences Products
Click to view available options
Quantity:
1 x 1 mL
6 x 3.5 mL
Type:
ACCURUN 800 ToRCH Serology Negative Control
ACCURUN 810 Multi-analyte Serology Negative Control
Description
- Enhance quality control and quality assurance in your testing lab
- Human plasma-based controls mimic patient samples
- Independent controls meet compliance requirements of regulatory agencies and professional organizations
- Liquid, ready-to-use–no reconstitution or special handling required
- Extended shelf life means efficiency for your lab, allows you to monitor assay performance with same lot over an extended period of time
- Combine LabLink xL with the ACCURUN products for an IVD exclusive infectious disease and nucleic acid testing Quality Assurance Program (QAP) from Fisher HealthCare
- With the LabLink xL QAP program, a lab's performance can be compared to peer laboratories' performances and used to benchmark performance to group standards:
- Track how other lab's signal to cutoff ratio (s/co) or recovered values (mean values) compare
- Compare how a lab's variability (standard deviation) compares to a group average
- Determine if a lab's s/co or recovered values are statistically within acceptable group limits
Compliance
For in vitro diagnostic use; CE-approved
Specifications
Specifications
Certifications/Compliance | IVD, CE, HC |
Content And Storage | 2°C to 8°C |
For Use With (Equipment) | Any system |
Type | ACCURUN 800 ToRCH Serology Negative Control |
Intended Use | Detection of IgG and IgM Antibodies to Toxoplasma gondii, Rubella Virus, Cytomegalovirus, and Herpes Simplex Virus |
Quantity | 1 x 1 mL |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction